PathAI vs Recursion

Side-by-side comparison of PathAI and Recursion: pricing, features, API access, and community ratings.

AI comparison summary
Generating comparison…
PathAI
PathAI

AI-powered pathology platform to improve patient outcomes through precision diagnostics

Visit
Recursion
Recursion

Pioneering AI-driven drug discovery to decode biology and radically improve lives

Visit
Category
Healthcare & biotech
Healthcare & biotech
Pricing
Enterprise
Enterprise
Starting price
Free tier
Audience
Technical
Technical
API available
Open source
Self-hostable
Model provider
PathAI (proprietary)
Proprietary (Recursion OS)
Founded
2016
2013
Headquarters
Boston, USA
Salt Lake City, USA
Key strengths
  • ·AI-powered pathology algorithms
  • ·Large proprietary pathologist contributor network (450+ board-certified pathologists)
  • ·Extensive annotation dataset (32.5M+ annotations)
  • ·FDA-cleared digital pathology platform (AISight® Dx)
  • ·Massive proprietary biological dataset (>50 petabytes) spanning phenomics, transcriptomics, proteomics, and more
  • ·Automated wet lab with robotics and computer vision generating millions of cell experiments per week
  • ·Recursion OS — a continuously improving AI drug discovery and development platform
  • ·BioHive-2 supercomputer built with NVIDIA for biopharma-scale compute